Novel Bile Salt Stabilized Nano-Colloidal Carriers For Oral Vaccine Delivery
Speaker(s):
- Anshuman Shukla, PhD, Panjab University, Chandigarh, India
Stabilization of the SARS-CoV-2 Spike receptor-binding domain using deep mutational scanning and structure-based design
Speaker(s):
- Daniel Ellis, PhD, University of Washington
Moving beyond the titer paradigm: rational design of a next-gen glycoconjugate vaccine inducing highly functional antibodies
Speaker(s):
- Giuseppe Stefanetti, PhD, Harvard Medical School
First recombinant dual-hit glycoconjugate vaccine production platform to combat Group A Streptococcus
Speaker(s):
- Helge C. Dorfmueller, PhD, University of Dundee
Vaccine nanoparticles for elicitation of strong cellular and humoral immune responses.
Speaker(s):
- James J. Moon, PhD, University of Michigan, Ann Arbor
Potent neutralizing humoral and cellular responses induced by SARS-CoV-2 Spike protein – polymeric glyco-adjuvant conjugate
Speaker(s):
- Michal M. Raczy, MS, University of Chicago
Sterilizing Antiviral Immunity Induced by a CD40L-Based Vaccine
Speaker(s):
- Richard Kornbluth, MD, PhD, Multimeric Biotherapeutics, Inc.
BCG & Cyclic Dinucleotides join hands in fight against Tuberculosis and Viral Diseases- Novel approach towards developing a low cost PAN Corona vaccine.
Speaker(s):
- Ruchi Jain Dey, PhD, BITS Pilani Hyderabad Campus
COVID-19 Pathogen (SARS-Cov-2) Viral Evolution Leading to Increased Infectivity
Speaker(s):
- Sonam Parag, BS, Nova Southeastern University Dr. Kiran C. Patel College of Allopathic Medicine
Assessing RNA recombination between an alphavirus replicon vector vaccine and wildtype alphaviruses
Speaker(s):
- Tessy A. Hick, MSc, Wageningen University